コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 mbination of antihistamines, colchicine, and dapsone.
2 ng a combination of glucocorticosteroids and dapsone.
3 vitro, and it possessed activity similar to dapsone.
4 ee antibiotics: rifampicin, clofazimine, and dapsone.
5 one and from 3.2 to 3.8 A in the presence of dapsone.
6 se in resistance to S/P or to chlorproguanil-dapsone.
7 tient is placed on a gluten-free diet and/or dapsone.
8 reased (decrease in K(S)) by the presence of dapsone.
9 en in the presence and absence of 100 microM dapsone.
10 ersensitivity caused by sulfamethoxazole and dapsone.
11 ing resistance to sulfamethoxazole (SMX) and dapsone.
12 rson-years; relative risk for atovaquone vs. dapsone, 0.85; 95 percent confidence interval, 0.67 to 1
13 ne (-6.7%, -45.9 to 22.0) nor chlorproguanil-dapsone (10.8%, -24.6 to 36.1) had a protective effect.
14 y atovaquone (1500-mg suspension) with daily dapsone (100 mg) for the prevention of P. carinii pneumo
15 smission sites), chlorproguanil (15 mg) plus dapsone (18.75 mg; n=317 and 285), mefloquine (125 mg; n
16 in distance from the heme in the presence of dapsone, 3.50 A, as compared to the absence of dapsone,
17 od is based on the diazotization reaction of dapsone (4,4'-diamino-diphenyl sulphone, DAP) and (napht
18 ials of antimalarial preparations containing dapsone (4,4'-diaminodiphenylsulfone; 2.5 mg/kg once dai
20 nts was 3.78 for atovaquone as compared with dapsone (95 percent confidence interval, 2.37 to 6.01; P
21 ion of phenanthrene metabolism by CYP3A4 and dapsone activation of flurbiprofen and naproxen metaboli
26 e ranged from 4.2 to 4.5 A in the absence of dapsone and from 3.2 to 3.8 A in the presence of dapsone
30 the closed loop 1; (ii) the distribution of dapsone and sulfonamide resistance mutations; (iii) the
31 d by gluten-free diet (with poor adherence), dapsone, and conventional immune-suppressing agents resp
34 m-dependent toxicity of sulfamethoxazole and dapsone, and subsequent incubation of normal human epide
35 rimethoprim-sulfamethoxazole, atovaquone and dapsone are similarly effective for the prevention of P.
36 involving 872 participants who had received dapsone as part of multidrug therapy for leprosy (39 par
37 lticenter trials highlighted doxycycline and dapsone as valuable medications in the treatment of bull
38 to 6.01; P<0.001); among those not receiving dapsone at base line, it was 0.42 (95 percent confidence
39 Among the 546 patients who were receiving dapsone at base line, the relative risk of discontinuati
41 usly in the active site with the presence of dapsone causing flurbiprofen to be oriented more closely
42 assess the safety profile of chlorproguanil-dapsone (CD), and to compare the safety and efficacy of
45 ulfadoxine-pyrimethamine, and chlorproguanil-dapsone for the treatment of P vivax malaria was conduct
46 n-years), as compared with 135 of 521 in the dapsone group (18.4 cases per 100 person-years; relative
50 01 was confirmed to be a risk factor for the dapsone hypersensitivity syndrome (odds ratio, 20.53; P=
51 loci, was significantly associated with the dapsone hypersensitivity syndrome among patients with le
52 1 was associated with the development of the dapsone hypersensitivity syndrome among patients with le
53 Ps in an additional 31 participants with the dapsone hypersensitivity syndrome and 1089 controls and
55 herapy for leprosy (39 participants with the dapsone hypersensitivity syndrome and 833 controls), usi
56 a specificity of 85.7% as a predictor of the dapsone hypersensitivity syndrome, and its absence was a
59 to be widely used for leprosy treatment was dapsone in the 1950s, which had to be taken over several
65 enytoin (CYP-2C19), chlorzoxazone (CYP-2E1), dapsone (multiple CYP enzymes), and flurbiprofen (CYP-2C
66 ulcer margin; topical cromolyn sodium; oral dapsone, prednisone, cyclosporine, mycophenolate mofetil
69 ied primary drug resistance in 4 cases and a dapsone-resistant cluster caused by the same strain.
71 ty (pamaquine, sitamaquine, tafenoquine, and dapsone) resulted in loss of G6PD-deficient huRBCs compa
72 ydroxylation is activated by the presence of dapsone resulting in reduction of the K(m) for flurbipro
73 DRDRs) of folP1, rpoB, and gyrA, targets for dapsone, rifampin, and fluoroquinolones, real-time PCR-H
75 ratinocytes metabolized sulfamethoxazole and dapsone to N-4-hydroxylamine and N-acetyl derivatives in
76 s of the prototypical CYP2C9 heteroactivator dapsone to validate a simple docking method that can be
78 sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment for uncomplicated P. falciparum malari
79 methamine-sulfadoxine but not chlorproguanil-dapsone treatment, showing that a combination of these t
80 le typically managed by gluten-free diet and dapsone, treatment of DH refractory to standard treatmen
82 pyrimethamine-sulfadoxine or chlorproguanil-dapsone was analyzed for variants of the genes coding fo
85 eatment, a combination therapy consisting of dapsone with cimetidine and vitamin E to enhance drug ef
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。